These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10885565)

  • 1. Criteria to define HLA haplotype loss in human solid tumors.
    Ramal LM; Feenstra M; van der Zwan AW; Collado A; Lopez-Nevot MA; Tilanus M; Garrido F
    Tissue Antigens; 2000 May; 55(5):443-8. PubMed ID: 10885565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
    Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
    Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
    Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
    Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
    Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
    McEvoy CR; Seshadri R; Morley AA; Firgaira FA
    Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
    Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
    Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
    Jiménez P; Cantón J; Collado A; Cabrera T; Serrano A; Real LM; García A; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1999 Sep; 83(1):91-7. PubMed ID: 10449614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
    Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
    Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype.
    Arias-Pulido H; Joste N; Wheeler CM
    Genes Chromosomes Cancer; 2004 Aug; 40(4):277-84. PubMed ID: 15188450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.
    Yeung JT; Hamilton RL; Ohnishi K; Ikeura M; Potter DM; Nikiforova MN; Ferrone S; Jakacki RI; Pollack IF; Okada H
    Clin Cancer Res; 2013 Apr; 19(7):1816-26. PubMed ID: 23401227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia.
    McEvoy CR; Morley AA; Firgaira FA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):321-5. PubMed ID: 12759931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of heterozygosity on chromosome 6p in uveal melanoma.
    Metzelaar-Blok JA; Jager MJ; Moghaddam PH; van der Slik AR; Giphart MJ
    Hum Immunol; 1999 Oct; 60(10):962-9. PubMed ID: 10566596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
    Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
    Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
    Ryschich E; Cebotari O; Fabian OV; Autschbach F; Kleeff J; Friess H; Bierhaus A; Büchler MW; Schmidt J
    Tissue Antigens; 2004 Dec; 64(6):696-702. PubMed ID: 15546343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.
    Acevedo CM; Henríquez M; Emmert-Buck MR; Chuaqui RF
    Cancer; 2002 Feb; 94(3):793-802. PubMed ID: 11857315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity.
    de Nooij-van Dalen AG; van Buuren-van Seggelen VH; Mulder A; Gelsthorpe K; Cole J; Lohman PH; Giphart-Gassler M
    Mutat Res; 1997 Mar; 374(1):51-62. PubMed ID: 9067415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.